REGEN BIOPHARMA PFD A (RGBPP) Total Assets by Year
REGEN BIOPHARMA PFD A closed fiscal year 2025 with $275K in total assets, $6.6M in total liabilities and -$6.3M in shareholder equity. This represents an increase of 70.5% from the prior fiscal year. The table below carries 13 fiscal years, from 2013 to 2025, and the quarters REGEN BIOPHARMA PFD A has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
RGBPP Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $275K+70.5% | $161K-54.4% | $354K-36.7% | $559K-53.9% | $1.2M+883.9% | $123K+24.3% | $99K-52.6% | $209K-77.9% | $944K+195.7% | $319K+44.9% | $220K+1969.0% | $11K-90.8% | $116K |
| Total Liabilities | $6.6M+21.9% | $5.4M-1.5% | $5.5M-36.5% | $8.6M-41.5% | $14.7M+97.1% | $7.5M-32.2% | $11.0M+18.0% | $9.3M+50.6% | $6.2M+583.6% | $906K+185.3% | $318K+126.4% | $140K | $0 |
| Total Equity | -$6.3M-20.4% | -$5.2M-2.2% | -$5.1M+36.5% | -$8.0M+40.4% | -$13.5M-83.9% | -$7.3M+32.8% | -$10.9M-19.6% | -$9.1M-73.7% | -$5.3M-794.8% | -$587K-503.9% | -$97K+25.0% | -$130K-211.8% | $116K |
RGBPP Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $288K+46.1% | $260K+53.5% | $237K+23.9% | $275K+70.5% | $197K+15.7% | $169K+20.4% | $191K+20.0% | $161K-54.4% | $170K-40.3% | $141K-65.4% | $160K-61.5% | $354K-36.7% |
| Total Liabilities | $6.2M+2.5% | $5.6M-4.2% | $6.8M+16.0% | $6.6M+21.9% | $6.0M+12.9% | $5.9M+10.4% | $5.9M+8.7% | $5.4M-1.5% | $5.3M+0.3% | $5.3M-0.4% | $5.4M+1.9% | $5.5M-36.5% |
| Total Equity | -$5.9M-1.1% | -$5.4M+6.0% | -$6.6M-15.7% | -$6.3M-20.4% | -$5.8M-12.8% | -$5.7M-10.1% | -$5.7M-8.3% | -$5.2M-2.2% | -$5.2M-2.6% | -$5.2M-5.0% | -$5.2M-7.3% | -$5.1M+36.5% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More REGEN BIOPHARMA PFD A financials
Frequently Asked Questions
What was REGEN BIOPHARMA PFD A's total assets in fiscal year 2025?
REGEN BIOPHARMA PFD A closed fiscal year 2025 with $275K in total assets, $6.6M in total liabilities and -$6.3M in shareholder equity.
How fast is REGEN BIOPHARMA PFD A's total assets growing?
REGEN BIOPHARMA PFD A (RGBPP) total assets rose by 70.5% year over year, from $161K to $275K in fiscal year 2025.
How has REGEN BIOPHARMA PFD A's total assets changed over the years?
Across the 13 fiscal years this page covers, REGEN BIOPHARMA PFD A (RGBPP) total assets went from $116K in fiscal year 2013 to $275K in fiscal year 2025.
What was REGEN BIOPHARMA PFD A's total assets in the most recent quarter?
REGEN BIOPHARMA PFD A (RGBPP) reported $288K in total assets in Q3 2026. This represents an increase of 46.1% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what REGEN BIOPHARMA PFD A (RGBPP) reported on that line in every period on record.